Increased butyrylcholinesterase levels in microsomal membranes of dystrophic Lama2(dy) mouse muscle

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 1138-1144

  Moral Naranjo, María Teresa ^a   Campoy, Francisco Javier ^a   Cabezas Herrera, Juan ^a   Vidal, Cecilio J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Butyrylcholinesterase; Glycosylation; Molecular components; Muscular dystrophy

Indexed keywords

CHOLINESTERASE; LECTIN; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ENZYME BINDING; ENZYME SYNTHESIS; GLYCOSYLATION; MICROSOME; MICROSOME MEMBRANE; MOUSE; MUSCLE; MUSCLE DEVELOPMENT; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; RICINUS COMMUNIS; SARCOPLASMIC RETICULUM;

ANIMALS; BUTYRYLCHOLINESTERASE; GLYCOSYLATION; LAMININ; LECTINS; MICE; MICE, NEUROLOGIC MUTANTS; MICROSOMES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PHENOTYPE;

EID: 0032838527     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731138.x     Document Type: Article

References (44)

1. Arahata K., Hayashi Y. K., Koga R., Goto K., Lee J. H., Miyagoe Y., Ishii H., Tsukahara T., Takeda S., Woo M., Nonaka I., Matsuzaki T., and Sugita H. (1993) Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscle and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc. Jpn. Acad. B 69, 259-264.
2. Balasubramanian A. S. and Bhanumathy C. D. (1993) Noncholinergic functions of cholinesterases. FASEB J. 7, 1354-1358.
3. Berman H. A., Decker M. M., and Jo S. (1987) Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscle. Dev. Biol. 120, 154-161.
4. Brockman S. K., Usiak M., and Younkin S. G. (1986) Assembly of monomeric acetylcholinesterase into tetrameric and asymmetric forms. J. Biol. Chem. 261, 1201-1207.
5. Cabezas-Herrera J., Campoy F. J., and Vidal C. J. (1994a) Amphiphilic properties of molecular forms of acetylcholinesterase in normal and dystrophic muscle. J. Neurosci. Res. 38, 505-514.
6. 4 forms of acetylcholinesterase and butyrylcholinesterase in normal and dystrophic mouse muscle differ in their interaction with Ricinus communis agglutinin. Biochim. Biophys. Acta 1225, 283-288.
7. dy mouse muscle. J. Neurochem. 69, 1964-1974.
8. Campbell K. P. (1995) Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
9. Campoy F. J., Cabezas-Herrera J., and Vidal C. J. (1992) Interaction of AChE with Lens culinaris agglutinin reveals differences in glycosylation of molecular forms in sarcoplasmic reticulum membrane subfractions. J. Neurosci. Res. 33, 568-578.
10. Chapron J., De La Porte S., Delépine L., and Koenig J. (1997) Schwann cells modify expression of acetylcholinesterase and butyrylcholinesterase at rat neuromuscular junctions. Eur. J. Neurosci. 9, 260-270.
11. Chatonnet A. and Lockridge O. (1989) Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260, 625-634.
12. +-ATPase content is elevated in mdx mice: implications for the regulation of ions in dystrophic muscle. J. Neurol. Sci. 133, 11-15.
13. 4) acetylcholinesterase: structure, localization, and physiological regulation. J. Neurochem. 66, 1335-1346.
14. Geula C. and Mesulam M. M. (1995) Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9, 23-28.
15. 4 acetylcholinesterase characterizing fast muscles and its alteration in murine muscular dystrophy. J. Neurosci. Res. 19, 62-78.
16. Grady R. M., Teng H., Nichol M. C., Cunningham J. C., Wilkinson R. S., and Sanes J. R. (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729-738.
17. Greenfield S. (1996) Critique: non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 485-490.
18. Hayashi Y. K., Koga R., Tsukahara T., Ishii H., Matsuishi T., Yamashita Y., Nonaka I., and Arahata K. (1995) Deficiency of laminin alpha-2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 18, 1027-1030.
19. Jbilo O., L'Hermite Y., Talesa V., Toutant J. P., and Chatonnet A. (1994) Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development. Eur. J. Biochem. 225, 115-124.
20. Jeanpierre M., Carrié A., Piccolo F., Leturcq F., Azibi K., De Toma C., Beldjord C., Merlini L., Voit T., Romero N., Sunada Y., Tomé F. M. S., Fardeau M., Campbell K. P., and Kaplan J. C. (1996) From adhalinopathies to alpha-sarcoglycanopathies: an overview. Neuromuscul. Disord. 6, 463-465.
21. Koenig J., De La Porte S., and Chapron J. (1998) The Schwann cell at the neuromuscular junction. J. Physiol. (Paris) 92, 153-155.
22. Kornfeld R. and Kornfeld S. (1985) Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631-664.
23. Layer P. G. (1995) Nonclassical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9, 29-36.
24. Layer P. G., Alber R., and Rathjen F. G. (1988) Sequential activation of butyrylcholinesterase in rostral half somites and acetylcholinesterase in motoneurons and myotomes preceding growth of motor axons. Development 102, 387-396.
25. Layer P. G., Weikert T., and Alber R. (1993) Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell. Tissue Res. 273, 219-226.
26. Massoulié J., Pezzementi L., Bon S., Krejci E., and Vallette F. M. (1993) Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
27. Mattes C. E., Lynch T. J., Singh A., Bradley R. M., Kellaris P. A., Brady R. O., and Dretchen K. L. (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol. Appl. Pharmacol. 145, 372-380.
28. Moral-Naranjo M. T., Cabezas-Herrera J., and Vidal C. J. (1996) Molecular forms of acetyl-and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43, 224-234.
29. dy mice. Neurosci. Lett. 226, 45-48.
30. Niebroj-Dobosz I., Kornguth S., Schutta H. S., and Siegel F. L. (1989) Elevated calmodulin levels and reduced calmodulin-stimulated calcium-ATPase in Duchenne muscular dystrophy. Neurology 39, 1610-1614.
31. Ozawa E., Noguchi S., Mizuno Y., Hagiwara Y., and Yoshida M. (1998) From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 21, 421-438.
32. Roberts R. G. (1995) Dystrophin, its gene, and the dystrophinopathies. Adv. Genet. 33, 177-231.
33. Robitzki A., Mack A., Chatonnet A., and Layer P. G. (1997) Transfection of reaggregating embryonic chicken retinal cells with an antisense 5′-DNA butyrylcholinesterase expression vector inhibits proliferation and alters morphogenesis. J. Neurochem. 69, 823-833.
34. Rotundo R. L., Thomas K., Porter-Jordan K., Benson R. J. J., Fernandez-Valle C., and Fine R. E. (1989) Intracellular transport, sorting and turnover of acetylcholinesterase. J. Biol. Chem. 264, 3146-3152.
35. Schwarz M., Glick D., Loewenstein Y., and Soreq H. (1995) Engineering of human cholinesterase explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol Ther. 67, 283-322.
36. Seidman S., Ben Aziz-Aloya R., Timberg R., Loewenstein Y., Velan B., Shafferman A., Liao J., Norgaard-Pedersen B., Brodbeck U., and Soreq H. (1994) Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos. J. Neurochem. 62, 1670-1681.
37. Sewry C. A., Philpot J., Sorokin L. M., Wilson L. A., Naom I., Goodwin F., D'Alessandro M., Dubowitz V., and Muntoni F. (1996) Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 347, 582-584.
38. Skau K. A. (1990) On the specificity of the acetylcholinesterase defect in dystrophic mice. Muscle Nerve 13, 321-325.
39. Sternfeld M., Ming G. L., Song H. J., Sela K., Timberg R., Poo M. M., and Soreq H. (1998) Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C-termini. J. Neurosci. 18, 1240-1249.
40. 2j mice. Hum. Mol. Genet. 4, 1055-1061.
41. Taylor P. and Radic Z. (1995) The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281-320.
42. Tornel P. L., Sáez-Valero J., and Vidal C. J. (1992) Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid. Neurosci. Lett. 145, 59-62.
43. Winder S. J. (1997) The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J. Muscle Res. Cell Motil. 18, 617-629.
44. Xu H., Christmas P., Wu X. R., Wever U. M., and Engvall E. (1994) Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA 91, 5572-5576.